This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoshiko, Y. Articles by Aubin, J. E. Search for Related Content PubMed PubMed Citation Articles by Yoshiko, Y. Articles by Aubin, J. E.

Stanniocalcin 1 Stimulates Osteoblast Differentiation in Rat Calvaria Cell Cultures

Department of Oral Growth and Developmental Biology, Hiroshima University Graduate School of Biomedical Sciences (Y.Y., N.M.), Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553, Japan; and Department of Molecular and Medical Genetics, Faculty of Medicine, University of Toronto (Y.Y., J.E.A.), Toronto, Ontario, Canada M5S 1A8

Address all correspondence and requests for reprints to: Jane E. Aubin, Ph.D., Department of Molecular and Medical Genetics, Faculty of Medicine, University of Toronto, Room 6230, Medical Sciences Building, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: jane.aubin{at}utoronto.ca.

Stanniocalcin 1 (STC1) is a mammalian homolog of STC, the fish calcium/phosphate-regulating polypeptide whose functions are only beginning to be elucidated. Recently, we demonstrated that STC1 stimulates, in an autocrine/paracrine fashion, bone mineralization by increasing phosphate uptake in osteoblasts apparently via the functional activity of the sodium-dependent phosphate transporter, Pit1. We have now assessed the role of STC1 on osteoblast development in fetal rat calvaria (RC) cell cultures. STC1 mRNA and protein were differentially expressed over the time course of cultures, and dexamethasone, a potent stimulator of differentiation in this model, shifted peak STC1 expression levels to earlier times. Overexpression [recombinant human (rh) STC1] and underexpression (antisense oligonucleotides) of STC1 accelerated and retarded, respectively, osteogenic development as well as osteopontin and osteocalcin mRNA expression in mature osteoblast cultures, but not osteoprogenitor cell cultures. Dexamethasone shifted the effective doses required for these effects to higher and lower concentrations of antisense oligonucleotides and rhSTC1, respectively. Concomitantly, rhSTC1 increased both sodium-dependent phosphate uptake and Pit1 gene expression in nodule formation stages, but not in primitive progenitor stages of RC cell cultures. Thus, STC1 accelerates osteoblast development in an autocrine/paracrine manner in the RC cell culture model.

This article has been cited by other articles:

				A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth Endocrinology, May 1, 2008; 149(5): 2403 - 2410. [Abstract] [Full Text] [PDF]

				T Ichikawa, K Horie-Inoue, K Ikeda, B Blumberg, and S Inoue Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells J. Mol. Endocrinol., October 1, 2007; 39(4): 239 - 247. [Abstract] [Full Text] [PDF]

				Y. Yoshiko, G. A. Candeliere, N. Maeda, and J. E. Aubin Osteoblast Autonomous Pi Regulation via Pit1 Plays a Role in Bone Mineralization Mol. Cell. Biol., June 15, 2007; 27(12): 4465 - 4474. [Abstract] [Full Text] [PDF]

				S. Wu, Y. Yoshiko, and F. De Luca Stanniocalcin 1 Acts as a Paracrine Regulator of Growth Plate Chondrogenesis J. Biol. Chem., February 24, 2006; 281(8): 5120 - 5127. [Abstract] [Full Text] [PDF]

				D. G. Phinney, K. Hill, C. Michelson, M. DuTreil, C. Hughes, S. Humphries, R. Wilkinson, M. Baddoo, and E. Bayly Biological Activities Encoded by the Murine Mesenchymal Stem Cell Transcriptome Provide a Basis for Their Developmental Potential and Broad Therapeutic Efficacy Stem Cells, January 1, 2006; 24(1): 186 - 198. [Abstract] [Full Text] [PDF]

				Y. Sato, R. Nakamura, M. Satoh, K. Fujishita, S. Mori, S. Ishida, T. Yamaguchi, K. Inoue, T. Nagao, and Y. Ohno Thyroid Hormone Targets Matrix Gla Protein Gene Associated With Vascular Smooth Muscle Calcification Circ. Res., September 16, 2005; 97(6): 550 - 557. [Abstract] [Full Text] [PDF]

				A. D. Gagliardi, E. Y. W. Kuo, S. Raulic, G. F. Wagner, and G. E. DiMattia Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E92 - E105. [Abstract] [Full Text] [PDF]

				C.-W. Luo, K. Kawamura, C. Klein, and A. J. W. Hsueh Paracrine Regulation of Ovarian Granulosa Cell Differentiation by Stanniocalcin (STC) 1: Mediation through Specific STC1 Receptors Mol. Endocrinol., August 1, 2004; 18(8): 2085 - 2096. [Abstract] [Full Text] [PDF]